Table 2.
General indications and contraindications of uterine artery embolization in patients with uterine leiomyomas.
| Indications | |
| (1) Hypermenorrhea and/or dysmenorrhea | |
| (2) Absence of a malignant tumor in the uterus and lesion in the adnexa | |
| (3) Absence of a pelvic inflammatory disease | |
| (4) No childbearing | |
| Contraindications | |
| (1) No symptoms | |
| (2) Large leiomyoma (more than 10 cm in diameter) and/or multiple leiomyomas | |
| (3) Coexistence of a malignant tumor in the uterus or a lesion in the adnexa | |
| (4) Active pelvic inflammatory disease | |
| (5) Hormone therapy (required for 8–12 weeks after the therapy) | |
| (6) During pregnancy | |
| (7) Menopause | |
| (8) Hope of childbearing | |
| (9) Allergy to iodine |
Department of Radiology, National Defense Medical College Hospital, Japan.